Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (2016 - 2025)

Enanta Pharmaceuticals' Interest Coverage Ratio history spans 9 years, with the latest figure at 3.65 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 69.58% year-over-year to 3.65; the TTM value through Dec 2025 reached 8.3, up 28.84%, while the annual FY2025 figure was 11.11, 0.11% changed from the prior year.
  • Interest Coverage Ratio reached 3.65 in Q4 2025 per ENTA's latest filing, up from 7.7 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 3.65 in Q4 2025 to a low of 18.38 in Q2 2023.
  • Average Interest Coverage Ratio over 3 years is 11.12, with a median of 11.57 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: fell 18.36% in 2024, then skyrocketed 69.58% in 2025.
  • A 3-year view of Interest Coverage Ratio shows it stood at 10.14 in 2023, then fell by 18.36% to 12.0 in 2024, then surged by 69.58% to 3.65 in 2025.
  • Per Business Quant, the three most recent readings for ENTA's Interest Coverage Ratio are 3.65 (Q4 2025), 7.7 (Q3 2025), and 11.68 (Q2 2025).